Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome
Hypertension is common in hemolytic uremic syndrome (HUS) and often difficult to control. Local renin-angiotensin activation is believed to be an important part of thrombotic microangiopathy, leading to a vicious cycle of progressive renal injury and intractable hypertension. This has been demonstra...
Main Authors: | V Raghunathan, S K Sethi, M A Dragon-Durey, M Dhaliwal, R Raina, P Jha, S B Bansal, V Kher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2017;volume=27;issue=2;spage=136;epage=140;aulast=Raghunathan |
Similar Items
-
Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced
by: S K Sethi, et al.
Published: (2017-01-01) -
A detailed physiologically-based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine renin-angiotensin-aldosterone system
by: Karina eClaassen, et al.
Published: (2013-02-01) -
Atypical hemolytic uremic syndrome: a brief review
by: Kuixing Zhang, et al.
Published: (2017-06-01) -
Concurrent Atypical Hemolytic Uremic Syndrome and Autoimmune Hemolytic Anemia: a case report
by: Sayed Yousef Mojtahedi, et al.
Published: (2018-09-01) -
Optimal management of atypical hemolytic uremic disease: challenges and solutions
by: Raina R, et al.
Published: (2019-09-01)